期刊
AMERICAN JOURNAL OF HEMATOLOGY
卷 83, 期 7, 页码 596-598出版社
WILEY-LISS
DOI: 10.1002/ajh.21177
关键词
-
类别
Peripheral T-cell lymphoma (PTCL) is an aggressive form of non-Hodgkin's lymphoma (N - HL), associated with poor prognosis and without standard approach to treatment. Denileukin diftitox (Onta (R)) is a synthetic fusion protein combining the receptor-binding domain of interleukin-2 to the enzymatically active portion of diphtheria toxin. While approved for the treatment of cutaneous T-cell lymphoma, it has demonstrated activity in non-Hodgkin's lymphomas of both T-cell and B-cell origin. This report documents the first case of de novo maintenance therapy with denileukin diftitox sustaining an ongoing complete response at the molecular level for 2 years in a patient with PTCL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据